JCEM:高循环游离甲状腺素水平可能增加疲劳的风险!

2017-11-07 xing.T MedSci原创

在这项以人群为基础的研究中,甲状腺功能低下和亢进的参与者比甲状腺功能正常的参与者更易疲劳。然而,只有FT4水平较高的人随着时间的推移才会变得更疲劳。将FT4确定为健康恶化的潜在标志物可能对预测和预防疲劳具有意义。

甲状腺激素影响各种组织,器官和系统的代谢。然而,甲状腺功能对个体不良结局易感性的总体影响仍不清楚。近日,内分泌和代谢性疾病领域权威杂志Journal of Clinical Endocrinology & Metabolism上发表了一篇研究文章,研究人员旨在调查甲状腺功能与疲劳指数之间横断面和前瞻性关联,疲劳指数是一个已知的衡量总体健康状况的指标。

鹿特丹研究是一项以人群为基础的前瞻性队列研究。研究人员将具有基础甲状腺功能和疲劳指数的参与者纳入研究。研究人员测量了基础疲劳指数,中位随访时间为10.1(四分位间距为5.7-10.8)年。较高的疲劳指数表明健康状况较差。研究人员评估了基础甲状腺功能与疲劳程度,随访时疲劳程度与疲劳程度随时间变化之间的相关性,并对年龄,性别,队列,吸烟,饮酒和教育情况进行了调整。

研究人员纳入了9640名参与者(平均年龄为64.9岁)。研究人员发现TSH(P<0.0003)和FT4(P<0.0001)与基础疲劳指数之间存在U型关联。但与TSH无显著相关性,但是在随访期间和随时间变化的疲劳转变上,FT4与疲劳性呈正相关性(β=1.22;每单位FT4的可信区间为0.73-1.72)。

在这项以人群为基础的研究中,甲状腺功能低下和亢进的参与者比甲状腺功能正常的参与者更易疲劳。然而,只有FT4水平较高的人随着时间的推移才会变得更疲劳。将FT4确定为健康恶化的潜在标志物可能对预测和预防疲劳具有意义。

原始出处:


Arjola Bano,et al. High circulating free thyroxine levels may increase the risk of frailty: The Rotterdam Study.J Clin Endocrinol Metab. 2017.https://doi.org/10.1210/jc.2017-01854

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2063077, encodeId=6b8b20630e72f, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri Aug 03 07:50:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777695, encodeId=8be91e776959b, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260866, encodeId=5f53126086699, content=<a href='/topic/show?id=493ee0559a7' target=_blank style='color:#2F92EE;'>#疲劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70559, encryptionId=493ee0559a7, topicName=疲劳)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Thu Nov 09 08:50:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510585, encodeId=b1fb1510585fd, content=<a href='/topic/show?id=0032663e6ff' target=_blank style='color:#2F92EE;'>#游离甲状腺素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66376, encryptionId=0032663e6ff, topicName=游离甲状腺素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0410217579, createdName=xqptu, createdTime=Thu Nov 09 08:50:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259673, encodeId=1da72596e388, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Wed Nov 08 09:58:46 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259513, encodeId=ff8e259513bd, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Tue Nov 07 20:35:51 CST 2017, time=2017-11-07, status=1, ipAttribution=)]
    2018-08-03 achengzhao
  2. [GetPortalCommentsPageByObjectIdResponse(id=2063077, encodeId=6b8b20630e72f, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri Aug 03 07:50:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777695, encodeId=8be91e776959b, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260866, encodeId=5f53126086699, content=<a href='/topic/show?id=493ee0559a7' target=_blank style='color:#2F92EE;'>#疲劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70559, encryptionId=493ee0559a7, topicName=疲劳)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Thu Nov 09 08:50:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510585, encodeId=b1fb1510585fd, content=<a href='/topic/show?id=0032663e6ff' target=_blank style='color:#2F92EE;'>#游离甲状腺素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66376, encryptionId=0032663e6ff, topicName=游离甲状腺素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0410217579, createdName=xqptu, createdTime=Thu Nov 09 08:50:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259673, encodeId=1da72596e388, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Wed Nov 08 09:58:46 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259513, encodeId=ff8e259513bd, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Tue Nov 07 20:35:51 CST 2017, time=2017-11-07, status=1, ipAttribution=)]
    2018-01-07 smallant2015
  3. [GetPortalCommentsPageByObjectIdResponse(id=2063077, encodeId=6b8b20630e72f, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri Aug 03 07:50:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777695, encodeId=8be91e776959b, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260866, encodeId=5f53126086699, content=<a href='/topic/show?id=493ee0559a7' target=_blank style='color:#2F92EE;'>#疲劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70559, encryptionId=493ee0559a7, topicName=疲劳)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Thu Nov 09 08:50:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510585, encodeId=b1fb1510585fd, content=<a href='/topic/show?id=0032663e6ff' target=_blank style='color:#2F92EE;'>#游离甲状腺素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66376, encryptionId=0032663e6ff, topicName=游离甲状腺素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0410217579, createdName=xqptu, createdTime=Thu Nov 09 08:50:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259673, encodeId=1da72596e388, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Wed Nov 08 09:58:46 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259513, encodeId=ff8e259513bd, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Tue Nov 07 20:35:51 CST 2017, time=2017-11-07, status=1, ipAttribution=)]
    2017-11-09 tamgche
  4. [GetPortalCommentsPageByObjectIdResponse(id=2063077, encodeId=6b8b20630e72f, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri Aug 03 07:50:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777695, encodeId=8be91e776959b, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260866, encodeId=5f53126086699, content=<a href='/topic/show?id=493ee0559a7' target=_blank style='color:#2F92EE;'>#疲劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70559, encryptionId=493ee0559a7, topicName=疲劳)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Thu Nov 09 08:50:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510585, encodeId=b1fb1510585fd, content=<a href='/topic/show?id=0032663e6ff' target=_blank style='color:#2F92EE;'>#游离甲状腺素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66376, encryptionId=0032663e6ff, topicName=游离甲状腺素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0410217579, createdName=xqptu, createdTime=Thu Nov 09 08:50:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259673, encodeId=1da72596e388, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Wed Nov 08 09:58:46 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259513, encodeId=ff8e259513bd, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Tue Nov 07 20:35:51 CST 2017, time=2017-11-07, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2063077, encodeId=6b8b20630e72f, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri Aug 03 07:50:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777695, encodeId=8be91e776959b, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260866, encodeId=5f53126086699, content=<a href='/topic/show?id=493ee0559a7' target=_blank style='color:#2F92EE;'>#疲劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70559, encryptionId=493ee0559a7, topicName=疲劳)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Thu Nov 09 08:50:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510585, encodeId=b1fb1510585fd, content=<a href='/topic/show?id=0032663e6ff' target=_blank style='color:#2F92EE;'>#游离甲状腺素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66376, encryptionId=0032663e6ff, topicName=游离甲状腺素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0410217579, createdName=xqptu, createdTime=Thu Nov 09 08:50:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259673, encodeId=1da72596e388, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Wed Nov 08 09:58:46 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259513, encodeId=ff8e259513bd, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Tue Nov 07 20:35:51 CST 2017, time=2017-11-07, status=1, ipAttribution=)]
    2017-11-08 186****0580(小山羊)

    学习了谢谢了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2063077, encodeId=6b8b20630e72f, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri Aug 03 07:50:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777695, encodeId=8be91e776959b, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260866, encodeId=5f53126086699, content=<a href='/topic/show?id=493ee0559a7' target=_blank style='color:#2F92EE;'>#疲劳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70559, encryptionId=493ee0559a7, topicName=疲劳)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=674961, createdName=tamgche, createdTime=Thu Nov 09 08:50:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510585, encodeId=b1fb1510585fd, content=<a href='/topic/show?id=0032663e6ff' target=_blank style='color:#2F92EE;'>#游离甲状腺素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66376, encryptionId=0032663e6ff, topicName=游离甲状腺素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a0410217579, createdName=xqptu, createdTime=Thu Nov 09 08:50:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259673, encodeId=1da72596e388, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Wed Nov 08 09:58:46 CST 2017, time=2017-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259513, encodeId=ff8e259513bd, content=学习., beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/IgQVNoW5cFSgnREl4xSltTx9aCZ5QYxQnqcJgSduAAkRluhMSUuapklqicw0giaVFXPYAfEvmQW0CZiabZuwNiaNFw/0, createdBy=d5701970501, createdName=mimangzhe, createdTime=Tue Nov 07 20:35:51 CST 2017, time=2017-11-07, status=1, ipAttribution=)]
    2017-11-07 mimangzhe

    学习.

    0

相关资讯

2016SIE/AIT建议——应用左旋甲状腺素和左旋三碘甲状腺氨酸治疗甲状腺功能减退症发布

2016年7月,意大利内分泌学会(SIE)联合意大利甲状腺协会(AIT)共同发布了应用左旋甲状腺素和左旋三碘甲状腺氨酸治疗甲状腺功能减退症的临床建议,左旋甲状腺素(L-T4)建议作为甲状腺功能减退症的终生替代治疗药物,近期临床和实验数据支持添加左旋三碘甲状腺氨酸(L-T3)治疗一些特定的加减患者,本文的主要目的是为甲减患者联合应用L-T4和L-T3治疗定义正确的临床适应症,安排表,持续治疗时间和配

Int J Endocrinol:上海中山医院研究称,甲状腺素水平较高与肺动脉高压独立相关

近年来,甲状腺素水平与心血管疾病风险之间的关系越来越受到关注。研究表明,甲状腺素水平升高的人患动脉粥样硬化性疾病、出现心原性猝死的风险都较一般人群升高。 近期,来自复旦大学附属中山医院内分泌代谢科的一项研究表明,在甲状腺功能正常的冠心病患者中,血清游离甲状腺素(FT4)水平是肺动脉高压的独立危险因素,FT4与肺动脉收缩压独立相关,血清游离三碘甲状腺氨酸(FT3)和促甲状腺激素(TSH)水平则与肺